Autres langues

05/05 BioMarin Enters 'Transition Year' as Enzyme Portfolio Expands After Amicus Deal, Morgan Stanley Says
29/04 Amicus Therapeutics, Inc.(NasdaqGM:FOLD) dropped from S&P Global BMI Index
29/04 Amicus Therapeutics, Inc.(NasdaqGM:FOLD) dropped from S&P TMI Index
29/04 Amicus Therapeutics, Inc.(NasdaqGM:FOLD) dropped from S&P Biotechnology Select Industry Index
28/04 Amicus Therapeutics, Inc.(NasdaqGM:FOLD) dropped from Russell 3000E Index
28/04 Amicus Therapeutics, Inc.(NasdaqGM:FOLD) dropped from Russell 3000E Growth Benchmark
28/04 Amicus Therapeutics, Inc.(NasdaqGM:FOLD) dropped from Russell 3000 Growth Benchmark
28/04 Amicus Therapeutics, Inc.(NasdaqGM:FOLD) dropped from Russell 2500 Growth Benchmark
28/04 Amicus Therapeutics, Inc.(NasdaqGM:FOLD) dropped from Russell 2000 Growth Benchmark
28/04 Amicus Therapeutics, Inc.(NasdaqGM:FOLD) dropped from Russell 2500 Growth-Dynamic Index
28/04 Amicus Therapeutics, Inc.(NasdaqGM:FOLD) dropped from Russell 2000 Growth-Dynamic Index
28/04 Amicus Therapeutics, Inc.(NasdaqGM:FOLD) dropped from Russell 2500 Dynamic Index
28/04 Amicus Therapeutics, Inc.(NasdaqGM:FOLD) dropped from Russell 3000E Growth Index
28/04 Amicus Therapeutics, Inc.(NasdaqGM:FOLD) dropped from Russell 2500 Growth Index
28/04 Amicus Therapeutics, Inc.(NasdaqGM:FOLD) dropped from Russell 3000 Growth Index
28/04 Amicus Therapeutics, Inc.(NasdaqGM:FOLD) dropped from Russell Small Cap Comp Growth Index
28/04 Amicus Therapeutics, Inc.(NasdaqGM:FOLD) dropped from Russell Small Cap Completeness Index
28/04 Amicus Therapeutics, Inc.(NasdaqGM:FOLD) dropped from Russell 2000 Growth Index
28/04 Amicus Therapeutics, Inc.(NasdaqGM:FOLD) dropped from Russell 2500 Index
28/04 Amicus Therapeutics, Inc.(NasdaqGM:FOLD) dropped from Russell 3000 Index
28/04 Amicus Therapeutics, Inc.(NasdaqGM:FOLD) dropped from Russell 2000 Index
28/04 Amicus Therapeutics, Inc.(NasdaqGM:FOLD) dropped from Russell 2000 Dynamic Index
28/04 Amicus Therapeutics, Inc.(NasdaqGM:FOLD) dropped from Russell Small Cap Comp Growth Benchmark
27/04 BioMarin Seen Building Broader Rare-Disease Platform After Amicus Deal, Morgan Stanley Says
27/04 Amicus Therapeutics, Inc. Announces Board and Committees Changes, effective April 27, 2026
Aucun résultat pour cette recherche